The Centers for Disease Control and Prevention’s (CDC) vaccine panel recommended this week that the hepatitis B immunization should not be given to all babies immediately after birth. The decision was fully supported by President Donald Trump, who then took the issue one step further, signing a memorandum to “fast track” a full evaluation of the childhood vaccine schedule. The decision from the Advisory Committee on Immunization Practices, or ACIP, marks a major shift, changing up standard practice in the United States for some 30 years. In an 8-3 vote, the panel recommended the hepatitis B vaccine only be given at birth for infants whose mothers test positive for the virus, or whose status is unknown. If a mother has a negative hepatitis B status, she should speak to her doctor about getting the first dose of the vaccination at birth. Traditionally, the vaccine is given in three separate doses. The ACIP panel decided that some children do not need a third dose, and recommended testing children’s antibody levels before determining if they need follow-up doses. 50% off DailyWire+ annual memberships will not return for another year, so don’t miss this deal! Join now at DailyWire.com/cyberweek. On Friday, Trump posted on Truth Social that the decision from ACIP is “very good” and criticized the general vaccine schedule for children. “[T]he CDC Vaccine Committee made a very good decision to END their Hepatitis B Vaccine Recommendation for babies, the vast majority of whom are at NO RISK of Hepatitis B, a disease that is mostly transmitted sexually, or through dirty needles,” the president wrote. “The American Childhood Vaccine Schedule long required 72 ‘jabs,’ for perfectly healthy babies, far more than any other Country in the World, and far more than is necessary,” Trump continued. “In fact, it is ridiculous! Many parents and scientists have been questioning the efficacy of this ‘schedule,’ as have I!” Trump then announced that he signed a “Presidential Memorandum directing the Department of Health and Human Services to ‘FAST TRACK’ a comprehensive evaluation of Vaccine Schedules from other Countries around the World, and better align the U.S. Vaccine Schedule, so it is finally rooted in the Gold Standard of Science and COMMON SENSE!” “I am fully confident Secretary Robert F. Kennedy, Jr., and the CDC, will get this done, quickly and correctly, for our Nation’s Children,” the president added. “Thank you for your attention to this matter. MAHA!” Truth Social In addition to other notable changes, Kennedy’s Health and Human Services department has so far modified COVID vaccine recommendations, advised that young babies get vaccinated against chickenpox separately, and opened the door to exploring a connection between vaccines and autism. Related: Vax Panel Takes On COVID, Hep B, And MMRV Vaccines. Here’s What They Decided.

SpaceX has informed investors and representatives of financial institutions that it plans to pursue an initial public offering in the second half of next year, the Information reported on Friday, citing two people familiar with the discussions. The rocket-maker, founded by Elon Musk, is considering a public listing of the entire company, including Starlink, its internet satellite service, according the report. Musk had said in 2020 that SpaceX planned to list Starlink several years in the future, once its revenue growth became smooth and predictable. SpaceX did not immediately respond to a Reuters request for comment. The news of the potential IPO follows a media report that said SpaceX is kicking off a secondary share sale that would value the rocket-maker at $800 billion, pitting it against OpenAI for the title of the most valuable private company. SpaceX’s finance chief, Bret Johnsen, told investors about the sale in recent days, the Wall Street Journal reported earlier on Friday, citing people familiar with the matter. The new potential valuation is double the $400 billion value it fetched in a recent secondary share sale. 50% off DailyWire+ annual memberships will not return for another year, so don’t miss this deal! Join now at DailyWire.com/cyberweek. The $800 billion valuation would put SpaceX ahead of ChatGPT-parent OpenAI, which is valued at $500 billion as of October, making it the most valuable privately held company in the world, according to Crunchbase data. Separately, Bloomberg News on Friday reported that SpaceX is preparing to sell insider shares that could include a per-share price of around $300, which would value the company at roughly $560 billion. Several billionaires and private firms, including SpaceX and Jeff Bezos’ Blue Origin, are fueling a new space race in the U.S., pouring money into rockets, satellites and lunar missions. (Reporting by Juby Babu in Mexico City; Editing by Alan Barona)

EXCLUSIVE: Blue State's Election Quirk Might Just Result In It Having Republican Governor

J6 Bomber Family: He's Not MAGA. He's a Basement-Dwelling Loner With A Grudge.

'This Video Will Never Get Old': Let's All Remember the Time Tom Homan Left a Mushroom Cloud Over AOC

Can Trump End Birthright Citizenship? Supreme Court Says It Will Decide